Equities

22nd Century Group Inc

XXII:NAQ

22nd Century Group Inc

Actions
Consumer Staples Tobacco
  • Price (USD)1.08
  • Today's Change-0.150 / -12.20%
  • Shares traded311.21k
  • 1 Year change-99.10%
  • Beta1.3906
Data delayed at least 15 minutes, as of May 30 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.

  • Revenue in USD (TTM)29.75m
  • Net income in USD-62.89m
  • Incorporated2005
  • Employees64.00
  • Location
    22nd Century Group Inc8560 Main St Ste 4WILLIAMSVILLE 14221-7435United StatesUSA
  • Phone+1 (716) 270-1523
  • Fax+1 (716) 877-3064
  • Websitehttps://www.xxiicentury.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioCardia Inc468.00k-10.34m6.21m16.00------13.26-7.04-7.040.3132-1.270.0954--4.4429,250.00-210.81-107.34-1,190.90-154.17-----2,208.76-1,779.24---------64.72-5.262.82---28.89--
GT Biopharma Inc0.00-9.64m6.23m2.00--0.7513-----7.04-7.040.003.850.00----0.00-64.24-205.36-90.39--------------0.00------63.62------
Kineta Inc5.16m-17.89m6.24m11.00------1.21-1.55-1.550.4673-0.5640.6667----469,181.80-230.51-66.16---86.61-----345.77-854.74--------178.6513.8977.76------
Sunshine Biopharma Inc26.74m-4.09m6.25m44.00--0.0132--0.2338-13.35-13.3576.9624.960.90813.1311.58607,722.50-13.88-101.52-17.99-137.0433.1535.47-15.29-165.333.23--0.00--454.42--83.15--110.99--
NuCana PLC (ADR)0.00-33.74m6.34m25.00--0.5312-----301.53-301.530.005.650.00----0.00-72.34-41.01-125.17-48.07------------0.0324------13.71---21.70--
Titan Pharmaceuticals Inc87.00k-4.95m6.34m4.00--1.04--72.93-6.41-6.410.11196.660.0197--1.2321,750.00-112.41-96.80-170.59-156.65-----5,694.25-406.26---415.190.00---66.97-51.1645.43---65.61--
Intelligent Bio Solutions Inc2.83m-10.03m6.42m17.00--0.5392--2.27-64.14-64.144.603.820.20412.697.77166,299.40-72.67-80.65-107.67-224.8423.33---356.09-948.541.87--0.0451--187.51367.97-28.00------
Virios Therapeutics Inc0.00-5.07m6.61m4.00---------0.2673-0.26730.00--------------------------------------56.76------
22nd Century Group Inc29.75m-62.89m6.70m64.00------0.2252-40.02-97.9317.94-3.230.405.905.47464,796.90-66.29-46.78-92.49-54.18-33.09-2.11-165.75-107.950.4284-3.674.76---20.494.03-76.94--53.60--
Integrated BioPharma, Inc.50.57m-116.00k6.72m141.00--0.355231.680.1328-0.0041-0.00411.670.62831.884.4510.76358,617.00-0.43115.51-0.569827.947.0912.09-0.22946.441.02-9.000.001---9.913.00-101.35---14.03--
Kazia Therapeutics Ltd (ADR)14.92k-13.54m6.83m12.00--0.6561--457.55-0.821-0.8210.00080.34950.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
Actavia Life Sciences Inc0.00-406.65k6.95m1.00---------0.0005-0.00050.00-0.00280.00----0.00-805.97-158.17---------------5.63---------547.04------
Paranovus Entertainment Technology Ltd51.46m-42.62m6.97m80.00--0.6528--0.1355-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
Pulmatrix Inc11.68m-8.85m7.00m22.00--0.3683--0.5995-2.42-2.423.205.210.3517--17.84531,090.90-26.63-46.91-30.21-58.12-----75.73-238.04----0.00--20.21116.6225.03--104.29--
Viaderma Inc17.80m2.31m7.09m75.000.00030.000021.310.398516.8416.84129.62255.590.412624.691.21237,331.305.36--6.53--28.90--12.99--2.075.660.1718---29.15---40.70------
Data as of May 30 2024. Currency figures normalised to 22nd Century Group Inc's reporting currency: US Dollar USD

Institutional shareholders

5.87%Per cent of shares held by top holders
HolderShares% Held
Anson Funds Management LPas of 31 Mar 2024411.11k4.96%
The Vanguard Group, Inc.as of 31 Mar 202413.10k0.16%
Tidal Investments LLCas of 31 Mar 202412.68k0.15%
Geode Capital Management LLCas of 31 Mar 202411.95k0.14%
BlackRock Fund Advisorsas of 31 Mar 202411.85k0.14%
Group One Trading LPas of 31 Mar 20247.74k0.09%
Renaissance Technologies LLCas of 31 Mar 20245.24k0.06%
Two Sigma Investments LPas of 31 Mar 20245.16k0.06%
Andina Capital Management LLCas of 31 Mar 20244.30k0.05%
G1 Execution Services LLCas of 31 Mar 20243.85k0.05%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.